[1] |
de Koster EJ, Kist JW, Vriens MR, et al. Thyroid ultrasound-guided fine-needle Aspiration: the positive influence of on-site adequacy assessment and number of needle passes on diagnostic cytology rate[J]. Acta Cytol, 2016, 60(1): 39-45. DOI: 10.1159/000444917.
|
[2] |
Reuters KB, Mamone MCOC, Ikejiri ES, et al. Bethesda classification and cytohistological correlation of thyroid nodules in a brazilian thyroid disease center[J]. Eur Thyroid J, 2018, 7(3): 133-138. DOI: 10.1159/000488104.
|
[3] |
Abraham TM, de las Morenas A, Lee SL, et al. In thyroid fine-needle aspiration, use of bedside-prepared slides significantly increased diagnostic adequacy and specimen cellularity relative to solution-based samples[J]. Thyroid, 2011, 21(3): 237-242. DOI: 10.1089/thy.2010.0211.
|
[4] |
Cibas ES, Ali SZ. The 2017 bethesda system for reporting thyroid cytopathology[J]. J Am Soc Cytopathol, 2017, 6(6): 217-222. DOI: 10.1016/j.jasc.2017.09.002.
|
[5] |
Pitman MB, Abele J, Ali SZ, et al. Techniques for thyroid FNA: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference[J]. Diagn Cytopathol, 2008, 36(6): 407-424. DOI: 10.1002/dc.20829.
|
[6] |
Gharib H, Papini E, Garber JR, et al. American association of clinical endocrinologists, american college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update[J]. Endocr Pract, 2016, 22(5): 622-639. DOI: 10.4158/EP161208.GL.
|
[7] |
Zheng BW, Zarka MA, Chen CD, et al. The largest CAP-certified Chinese reference laboratory experience with the Bethesda system for reporting thyroid cytopathology: correlation with histologic and BRAF data[J]. J Am Soc Cytopathol, 2018, 7(1): 16-21. DOI: 10.1016/j.jasc.2017.07.002.
|
[8] |
Kuzan TY, Goret CC. Comparison of number of passes and cytopathological specimen adequacy for thyroid fine-needle aspiration biopsy in the absence of an on-site pathologist[J]. Eur Thyroid J, 2020, 9(1): 49-54. DOI: 10.1159/000504094.
|
[9] |
Zhu WJ, Michael CW. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases[J]. Diagn Cytopathol, 2007, 35(3): 183-186. DOI: 10.1002/dc.20552.
|
[10] |
Pastorello RG, Destefani C, Pinto PH, et al. The impact of rapid on-site evaluation on thyroid fine-needle aspiration biopsy: a 2-year cancer center institutional experience[J]. Cancer Cytopathol, 2018, 126(10): 846-852. DOI: 10.1002/cncy.22051.
|
[11] |
Shrestha M, Crothers BA, Burch HB. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: a 10-year study from a single institution[J]. Thyroid, 2012, 22(12): 1251-1256. DOI: 10.1089/thy.2012.0265.
|
[12] |
Paschke R, Hegedüs L, Alexander E, et al. Thyroid nodule guidelines: agreement, disagreement and need for future research[J]. Nat Rev Endocrinol, 2011, 7(6): 354-361. DOI: 10.1038/nrendo.2011.1.
|
[13] |
Grani G, Calvanese A, Carbotta G, et al. Intrinsic factors affecting adequacy of thyroid nodule fine-needle aspiration cytology[J]. Clin Endocrinol (Oxf), 2013, 78(1): 141-144. DOI: 10.1111/j.1365-2265.2012.04507.x.
|
[14] |
Zargham R, Johnson H, Anderson S, et al. Conditions associated with the need for additional needle passes in ultrasound-guided thyroid fine-needle aspiration with rapid on-site pathology evaluation[J]. Diagn Cytopathol, 2021, 49(1): 105-108. DOI: 10.1002/dc.24605.
|
[15] |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133. DOI: 10.1089/thy.2015.0020.
|